Manali Kamdar, MD, on Practical Considerations for Using CAR T-Cells for DLBCL

A review in the ASCO Educational Book provided management considerations for patients with primary refractory and early relapsed DLBCL. One of the two authors, Manali Kamdar, clinical director of Lymphoma Services at the University of Colorado Anschutz Medical Campus in Aurora, answered questions about the most important points.